ProMIS Neurosciences Inc PMN

Promis is compared to competition in this article

[retiredcop]

A long time investor located this article and passed it on for info.  



https://www.stockgumshoe.com/2022/07/alzheimers-drug-development-july-responses-to-questions-requests/

[M101]

Interesting opinion of the "unabashedly scornful" comments (re ACH) by Prof. Claude M. Wischik of TauRX, given that at their largely unhelpful website https://taurx.com/the-science/tau you'll find two facts we (both companies and their investors) all agree on: that "β-amyloid plaques are poorly correlated with clinical symptoms of dementia", and that "Misfolding of

[Lynx9]

After suffering, not once but twice, the reading of this article I have to say in as much certainly as I can embarrassing say - this was way over my head. The only paragraph that made any sense to me was the very last paragraph in the ProMIS section at the end of the article, Michal Jorrin, aka "Doc Gumshoe" a medical writer found what ProMIS is working on somewhat positive and will be

[M101]

You may find this utube interesting then https://www.youtube.com/watch?v=YxjFyDUYT5k it's not as bad as the opening music would suggest.

[retiredcop]

Theses articles can be very useless from an investor perspective . but the encourging thing is we were mentioned..  LIKE my hero Captain Jack Sparrow used to reply BRITSH officer : you are probably the worst pirate I have ever heard of"  Captain JACK:  " But you have heard of me  ( : 

[M101]

More useless for traders than investors, what investor doesn't want to read what seems like an objective perspective? And this article had the bonus of demonstrating how a competitor takes an alternative promotional strategy to differentiate from big pharma failures. 

[azzymaa]

m101 for the love of god please keep your mouth closed, are you okay in the head?